In this study, we designed a kind of AND Boolean logic–based supramolecular drug delivery system (HA-BPY-GEF-NPs) for the treatment of EGFR-TKI–resistant NSCLC (Fig. 1). This evidence concerns the gene EGFR and non-small cell lung carcinoma.